| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |